how AI is already improving colonoscopy quality – and why workflow integration is critical
why detection alone is not enough, and how usability, documentation and reporting drive adoption
what clinics should consider when evaluating AI in endoscopy, from evidence and implementation to long-term value
For gastroenterologists and hospital decision-makers, the key question is no longer whether to look at AI, but how and where it delivers real value today. Artificial intelligence has moved from promise to practice in colonoscopy, one of the most data-intensive areas within gastrointestinal endoscopy. While some AI systems are already used in routine colonoscopy, others remain closer to technology demonstrations.
This multimedia report provides a structured overview of what AI-assisted colonoscopy can already achieve, what evidence supports its use, where limitations and risks remain, and what clinics should consider before investing. MAIA Labs and its solution ColoMAIA serve as a concrete case study in colonoscopy to make this complex topic tangible. While the focus here is on AI-assisted colonoscopy, many of the discussed concepts are shaping the future of endoscopy more broadly.
Proven medical benefit of AI-assisted colonoscopy
The clinical evidence for AI-assisted colonoscopy is strong. Multiple recent studies show that AI can significantly increase both adenoma detection rate (ADR) and polyp detection rate (PDR). A large multicenter European study published in 2025 reported an ADR of 59.1 percent with AI support compared to 46.6 percent with standard colonoscopy, while PDR increased from 56.2 percent to 69.8 percent.
These improvements matter clinically: higher ADR is directly associated with a lower risk of interval colorectal cancer. At the same time, studies also show that AI does not replace good endoscopic technique – it acts as an assistive layer that supports consistency and attention.
Comparison of AI-assisted colonoscopy: fewer false-positive markers reduce visual distraction during the procedure.
AI in Colonoscopy – What the Data Shows
Adenoma detection increased from 46.6% to 59.1% with AI support
Polyp detection increased from 56.2% to 69.8%
Automated reporting can save 5–10 minutes per examination
In high-volume units, this can add up to more than one hour of physician time per day
The strongest relative detection gains are seen in less experienced endoscopists
AI in colonoscopy: Creating comparability in a crowded market
The market for AI in endoscopy is fragmented. Many solutions currently focus on colonoscopy, particularly on real-time detection (CADe), but they differ significantly in sensitivity, false-positive rates and functional scope.
For clinics, performance alone is not enough. Key questions increasingly include: What happens beyond detection? How well does AI integrate into existing workflows? And how much additional effort does it create – or eliminate? In practice, clinics should look at three dimensions: detection performance, workflow integration and operational impact.
Implementation and everyday usability of AI in colonoscopy
In clinical reality, adoption depends on usability. Systems that require additional hardware, manual steps, or complex post-processing are often underused. Successful AI solutions for colonoscopy integrate seamlessly into existing endoscopy towers, work vendor-independently and require minimal training.
of adenomas may be missed during standard colonoscopy, depending on lesion characteristics and procedural factors.
Economic impact of AI-assisted colonoscopy for hospitals
AI only becomes attractive if it makes operational sense. In colonoscopy, automated documentation, structured reporting, and direct integration into hospital information systems can significantly reduce administrative workload. Early real-world data suggest that automated reporting can reduce documentation time by up to 80 percent, saving five to ten minutes per examination and often more than one hour of physician time per day.
Improved detection performance may also affect quality indicators and reimbursement, making economic impact a relevant consideration for hospital management and procurement teams.
Case Study: ColoMAIA as an AI workflow solution for colonoscopy
Pushing the power button starts the ColoMAIA system.
A blank screen indicates the system is ready and waiting for the procedure to begin.
During colonoscopy, ColoMAIA runs in the background and supports the examination in real time.
Findings and workflow information are displayed directly on the screen as the procedure progresses.
MAIA Labs serves as an example of a broader shift in AI development – from standalone detection tools to workflow-oriented systems. They exemplify a new generation of AI solutions that move beyond detection alone. ColoMAIA combines real-time AI with end-to-end workflow automation – from patient identification and voice-based documentation to structured reporting and direct integration into hospital information systems (HIS).
The case study illustrates how AI can make colonoscopy not only more precise, but also more efficient and consistent. It highlights a broader trend: the real value of AI often lies in workflow and reporting, not in detection alerts alone.
Decision Support: What AI means for the future of colonoscopy and endoscopy
AI can measurably improve colonoscopy – but only when applied thoughtfully. The question is no longer whether AI belongs in endoscopy, but whether it is implemented in a way that clinicians actually trust and use. For clinics, the strategic questions remain: Does this system fit our workflows? Does it reduce complexity? Is the evidence convincing? And are we prepared for the organizational change AI adoption requires?
The team at MAIA Labs.
Author: Melanie Prüser | Editorial team MEDICA-tradefair.com
Melanie Prüser has been writing about the exciting interface between medicine and technology for MEDICA-tradefair.com since 2019. She is always on the lookout for the stories behind devices and applications to show how innovations directly change the everyday lives of medical professionals and patients.